written by reader Discussion page for Arch Therapeutics (ARTH)

By Lynn Clark, Stock Gumshoe, November 6, 2017

This page is for discussion of Arch Therapeutics (ARTH).

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

772
Share your thoughts...

avatar
186 Comment threads
586 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
138 Comment authors
blackngold63blackngold63deanbobfinventurerfrankw17 Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Kristilee
Irregular
πŸ‘402
Kristilee

Just came across this. Haven’t seen it posted here. https://www.zacks.com/research/get_news.php?id=6x79pzulaq

richardo8586
Member
πŸ‘510
richardo8586

I’m pretty sure this was previously posted Kristi lie. Not in $ARTH anymore, but cheering for those of you who still are

SoGiAm
Irregular
πŸ‘11466

$ARTH wow > 10-Q for the quarterly period ended March 31, 2018
https://ir.archtherapeutics.com/all-sec-filings/content/0001144204-18-022685/tv491272_10q.htm Let’s get this party started. πŸ™‚ #Best2ALL! πŸ™‚

Add a Topic
4393
finventurer
Irregular
πŸ‘352
finventurer

$ARTH atlas ow

what to expect of $ARTH, Gr8Full? nothing much happening before the ongoing “small, three-month long, non-invasive human study to provide the additional data to the FDA” is finished? or am i missing something?

Add a Topic
3022
blackngold63
Irregular
πŸ‘170
blackngold63

He’s just being a prick. He left the stock long ago. I guarantee ya he doesn’t even own a share.
I personally don’t think the science has changed. And – It is a low funded start-up biotech. Take your chances obviously.
And I guess we will see who comes out on the top at the end.

Add a Topic
5971
MarshallDillion
Irregular
πŸ‘76
MarshallDillion

Blackngold63. Are you talking about the guy looking back at you in the mirror?

finventurer
Irregular
πŸ‘352
finventurer

i sincerely wish you’d stop talking bad about probably the best contributor this site has ever had. Gr8tFull is on top of so many things most of us can’t even begin to comprehend so i’m afraid you comment is way out of line.

Only you are responsible for your acts, no one else.

Rest of your comment i agree with.

Thomas
Irregular
πŸ‘50
Thomas

Just another troll

hipockets
Irregular
πŸ‘1221

I started thinking about re-investing in ARTH after reading the 5/8/18 ARTH press release: “Arch intends to initiate the [sensitization] study in the next few weeks incorporating FDA’s comments and ….. expects to file the 510(k) notification in the third calendar quarter of 2018………..We still expect the trial to cost approximately $100,000 and take about three months.” Doing more research, I found that Arch Therapeutics Initiated a Clinical Trial of AC5 in Europe back in December, 2015 — https://www.fdanews.com/articles/174554-arch-therapeutics-to-initiate-clinical-trial-of-ac5-in-europe . I could find no reference to this trial on the ARTH website. Googling the topic, I found a link to… Read More Β»

finventurer
Irregular
πŸ‘352
finventurer

$ARTH atlas ow

hipockets, please do share your thoughts, if you have any more, regarding ARTH and latest press release πŸ™‚

I thought it was promising, as always, so wasn’t particularly thrilled and will wait for actual actions to be taken by the company and results to be seen. Will not trust plain words anymore.

JohnM
Irregular
πŸ‘1992

finventurer, if ARTH begins the three-month study on skin sensitivity to settle the only remaining outstanding issue for FDA approval, does that count as an “actual action?”

Add a Topic
3022
finventurer
Irregular
πŸ‘352
finventurer

i believe it does, JohnM πŸ™‚

JohnM
Irregular
πŸ‘1992

hipockets, Arch PR’d the results of the clinical trial here:
ir.archtherapeutics.com/press-releases/detail/483/arch-therapeutics-reports-ac5-topical-hemostatic-device
They then PR’d the peer-reviewed publication of the complete results here:
ir.archtherapeutics.com/press-releases/detail/502/dermatologic-surgery-publishes-clinical-data-on-arch

Griffin
Irregular
πŸ‘3607
Griffin

Thanks for the (no moderatatatater) links. πŸ˜‰

hipockets
Irregular
πŸ‘1221

$ARTH Thanks, JohnM, for the links. Your info gave me impetus to search for “ARTH CE Approval”. In their 3/12/18 press release, they stated “Arch also expects to file a CE mark in Europe for AC5 in the second half of 2018.” They have been saying they plan to apply for CE Approval every year since 2015, but they never explained why they did not file during those years. I emailed their IR department, and received this reply: “It is not approved in Europe yet but they are looking to gain the CE Mark in due course.” Not very informative… Read More Β»

arch1
Member
πŸ‘7795

Hipockets I cannot disagree. I have long felt that Norchi is not really able to shepherd #ARTH to market.
I hold far too much now and am at loss but still hopeful.
Same story for most of my bio.

JohnM
Irregular
πŸ‘1992

arch1, do you fell Norchi is unable to oversee a three-month human sensitivity trial, or do you think Norchi is not capable of negotiating a distribution deal? Or do you see some other obstacle keeping AC5 from the market?

JohnM
Irregular
πŸ‘1992

hipockts, I think you are being much too negative about ARTH management. (I am very OW.) 1. They did explain why they didn’t file for a CE mark. Their manufacturer told Norchi when they would file, which Norchi repeated to investors. The manufacturer then filled out the forms for a drug filing, which is what they were used to. But AC5 is a device, so they missed their timing. Having said that, I have no idea why it has taken this long for the manufacturer to prepare the correct filing form. I suspect it was unfamiliar to them and required… Read More Β»

Add a Topic
3022
Add a Topic
5971
Add a Topic
229
petervr
Irregular
πŸ‘1539
petervr

John – Many of us have been aboard ARTH for most of its circuitous journey and have heard most of the “stories”. Congratulations on your well thought out comments and observations, supported by a plethora of facts and details. It was a pleasure to read and makes a strong case. Thanks for your efforts to provide it.

Add a Topic
4393
hipockets
Irregular
πŸ‘1221

$ARTH — JohnM — Thank you for your excellent post. We all have heard about the “Gummy Bounce” – I think we saw a “JohnM Bounce” today! πŸ™‚ Please keep commenting! πŸ™‚

Cleveland
Irregular
πŸ‘6053

$ARTH

Nice post JohnM $ ARTH up 19 % !!!!!!!!!!!!!!!!!!

I got evicted from Dr. KSS’s forum. I have no idea why. He just canceled me out.

Such is life.

analog68
Irregular
πŸ‘389
analog68

Always good to hear from you Cleveland.

dunnydame
Irregular
πŸ‘1106
dunnydame

$ARTH
I’m actually above water on a couple of my accounts with this improved stock price. (Makes fervent prayer to the gods of the markets for continuation of this state of upness.)
Cleveland, I’m shocked that you were evicted from The Other Forum. Although a member, I haven’t been there for a little while as I have a life outside of taking care of my little stock portfolio and this is peak busy time.
I’m always glad to see your posts here.
Penny

Add a Topic
540
Add a Topic
5971
Add a Topic
5971
dzurej
Irregular
πŸ‘11
dzurej

Wait! What? YOU got banished? I thought you were his right hand man? I always knew he was a prima donna but it’s become more evident he may be bipolar or something. Wondering if I should continue to listen to his musings….

tceggjd
Member
πŸ‘19
tceggjd

$ARTH

I’m shocked … like Dzurej, I thought you were one of KSS’ go-to guys. Hard to tell what sets him off at times. I’ve done fairly well following his coverage but am always hesitant to comment because of what appears to be a very quick temper.

In any event, I’m always happy to read your insights.

OW ARTH

Griffin
Irregular
πŸ‘3607
Griffin

I’m not surprised. Science and Product are not the sole prerequisites for a successful Biotech. Management and finance are a good part of the remainder for success. Cleveland you have the best knowledge I’ve seen on Management and Finance undoubtedly due to your experience.

tfris
Member
πŸ‘315
tfris

Hi Cleveland,
Thanks for posting, hope you can post here once in a while if you feel like it.
Still long ARTH and hope they can refile 501k by 3rd quarter.

mes77
Member
πŸ‘69
mes77

Hi Cleveland,
KSS’s website is under construction and rebuild for a newer and better site. Could be a day or two but try to log on again soon.

Add a Topic
5916
jddeets
Member
πŸ‘76
jddeets

$ARTH – Long Biting the hand that feeds him appears to be a pattern. Considering all you have done for him over the years, I find that news appalling. I hope it’s a mistake. I may not always agree with your posts, but no one can argue the fact that that such posts are thoughtful, detailed, and well intentioned. It’s obvious you invest a lot of time. Despite publicly disparaging remarks made about this forum by a former contributor, and I might add, beneficiary, this forum provides an open dialogue where civil discourse is encouraged. Good to have you posting… Read More Β»

Add a Topic
3229
drbonz
Irregular
πŸ‘550
drbonz

Cleveland. Did you try to log on yesterday or today and get a messages that said, β€œThis website is currently unavailable”?

If so, you weren’t banished. Everyone gets this page at the present time due to construction on his site.

If not, and if you were truly banashed, then I’d love to know why. You have been invaluable in your analysis here and were KSS go to guy for all things ARTH. I hope it is the former.

richardo8586
Member
πŸ‘510
richardo8586

Cleveland, totally agree, not only with ARTH, but CLRB and others to numerous to mention. I miss your invaluable insight.

Rich

goodstock1
Irregular
πŸ‘4
goodstock1

Hey Cleveland. On one of his CC, KSS, near the start (so maybe was not on record at the time – I have not listened to playbacks for a while), said what a good person you were and was hopeful that you would return to his site. He implied you two might have had a disagreement but never said that. In so many words, he said he respected your opinions and comments! And that he hoped he would see you back! That you are welcome back at any time. I believe this must have been about the first of May/maybe… Read More Β»

J_M_Banks44
Irregular
πŸ‘130
J_M_Banks44

Long time lurker here. Was curious as to whether anyone had any insight into the following excerpt from $arth’s 2017 annual report that covers their ability to gain additional financing: “…we may continue to seek funding through additional collaborative arrangements with strategic partners if we determine them to be necessary or appropriate, although these arrangements could require us to relinquish rights to our technology or product candidates and could result in our receipt of only a portion of any revenues associated with the partnered product. We cannot provide any assurance that additional financing from these sources will be available on… Read More Β»

Add a Topic
4393